GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » EPS (Basic)

BioLight Life Sciences (XTAE:BOLT) EPS (Basic) : ₪-1.31 (TTM As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences EPS (Basic)?

BioLight Life Sciences's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was ₪0.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.31.

BioLight Life Sciences's EPS (Diluted) for the six months ended in Jun. 2024 was ₪0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.31.

BioLight Life Sciences's EPS without NRI for the six months ended in Jun. 2024 was ₪-0.74. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -1.58.

During the past 3 years, the average EPS without NRI Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, BioLight Life Sciences's highest 3-Year average EPS without NRI Growth Rate was 71.00% per year. The lowest was 9.10% per year. And the median was 21.60% per year.


BioLight Life Sciences EPS (Basic) Historical Data

The historical data trend for BioLight Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences EPS (Basic) Chart

BioLight Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.77 -2.95 0.08 -1.72 -5.60

BioLight Life Sciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 -2.22 -4.11 -1.49 0.18

BioLight Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BioLight Life Sciences's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-26.02-0)/4.644
=-5.60

BioLight Life Sciences's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.838-0)/4.658
=0.18

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLight Life Sciences  (XTAE:BOLT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioLight Life Sciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606
BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences Headlines

From GuruFocus